Athera Biotechnologies AB
Records under this name other than the patents Athera Biotechnologies AB holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
Showing 1 to 9 of 9 · Back to Athera Biotechnologies AB
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,295,716 | Methods for treating restenosis using annexin A5 Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,809,497 | Compounds and methods for the treatment of vascular disease Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,752,680 | Antibodies against phosphorylcholine in combination therapy with biologic agents Lapsed on the fee record Ended Aug 25, 2024 · From the USPTO record | Lapsed on the fee record | Ended Aug 25, 2024 | From the USPTO record |
| US 10,669,332 | Phosphorylcholine in combination therapy with infliximab Lapsed on the fee record Ended Jun 2, 2024 · From the USPTO record | Lapsed on the fee record | Ended Jun 2, 2024 | From the USPTO record |
| US 8,012,483 | Phosphorylcholine conjugates and corresponding antibodies Lapsed on the fee record Ended Sep 6, 2023 · From the USPTO record | Lapsed on the fee record | Ended Sep 6, 2023 | From the USPTO record |
| US 10,222,382 | Phosphorylcholine conjugates and corresponding antibodies Lapsed on the fee record Ended Mar 5, 2023 · From the USPTO record | Lapsed on the fee record | Ended Mar 5, 2023 | From the USPTO record |
| US 7,662,577 | Method of diagnosing cardiovascular disease Lapsed on the fee record Ended Feb 16, 2022 · From the USPTO record | Lapsed on the fee record | Ended Feb 16, 2022 | From the USPTO record |
| US 9,796,786 | Antibodies binding to phosphorylcholine (PC) and/or PC conjugates Formerly held Lapsed on the fee record Ended Oct 24, 2021 · From the USPTO record | Lapsed on the fee record | Ended Oct 24, 2021 | From the USPTO record |
| US 6,780,605 | Method of diagnosing cardiovascular disease and early atherosclerosis Lapsed on the fee record Ended Aug 24, 2016 · From the USPTO record | Lapsed on the fee record | Ended Aug 24, 2016 | From the USPTO record |